Today's blog reiterates my view that LymPro deal is atleast 3 months away. Right now, in Q4 2013, AMBS is conducting a small 60 patient LymPro clinical study to verify the sensitivity/specificity and side effects. If this is positive, then BD will pay AMBS and pps will cross 0.15.
Stop pumping and hallucinating when there is no news. Investors who do that, burn themselves forever.
0.475 now, just as I predicted the pps action to unfold. Cost average as much as possible, is all I can say. These opportunities will not be there forever. Read today's GC blog. At one point he says "marketplace will be updated shortly". Good luck. Today is a good day, especially with the pumpers/liars of RiskReturn/CreamyCum's kind staying away.
I am not an expert of the subject. It is mentioned in one of AMBS presentations online. Good luck. AMBS is on the right path. Name one company on the OTC that outlines its plans and future direction better than AMBS.